JPRN-UMIN000025749已完成未知
Effect of Canagliflozin on sympathetic activity and coronary plaque in DM patients with ACS - Effect of Canagliflozin on sympathetic activity and coronary plaque in DM patients with ACS
Dividion of Cardiology, Department of Medicine, Nihon University School of Medicine0 个研究点目标入组 46 人开始时间: 2017年1月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients receiving insulin injection for DM treatment 2.Severe heart failure 3.Advenced CKD(<eGFR30ml/min or HD) 4.Contraindication of Canagliflozin 5.patinets who are ineligible in the opinion of the investigator
研究者
相似试验
已完成
不适用
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)Type 2 diabetes mellitus patients with hypertensionJPRN-UMIN000023487Jichi Medical University School of Medicine100
进行中（未招募）
1 期
The effect of canagliflozin 300mg on glucose levels in people without diabetes after weight loss surgery.EUCTR2019-004041-32-GBniversity of Leicester24
已完成
不适用
The effect of canagliflozin on the blood sugar levels of people without diabetes after weight loss surgeryHypoglycaemia after eating due to weight-loss surgerySurgeryISRCTN11342830niversity of Leicester36
招募中
不适用
Effects of canagliflozin on endothelial function and epicardial adipose tissue in patients with type 2 diabetes mellitusType 2 diabetes mellitusJPRN-UMIN000035355Kawaguchi Municipal Medical Center70
已完成
不适用
Effect of SGLT2 inhibitor, canagliflozin, for the size of lipid particlesType 2 diabetesJPRN-UMIN000020027Tokyo Medical and Dental University Department of Medical Genetics / Gerontorgy30